Treatment of hypogonadism in males.

Sara Watson, John Fuqua, Peter A. Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The treatment of adolescent males with hypogonadism using testosterone is dependent on the underlying diagnosis as well as the patient's and family's preferences. Those with testicular failure, always a pathologic condition, begin lifelong therapy, while short-term therapy is often begun for those who have a delayed puberty. There is a wide variety of testosterone formulations available, with differences in adverse events sometimes associated with the method of administration. The goals of treatment involve stimulating physical puberty, including achievement of virilization, a normal muscle mass and bone mineral density for age, and improvement in psychosocial wellbeing. While androgen therapy results in physical changes of puberty, the potential for fertility must be considered for those with permanent gonadotropin deficiency. in this population, therapy with gonadotropins or gonadotropin releasing hormone may be effective. For those with testicular failure, fertility may be possible but requires assisted reproductive procedures.

Original languageEnglish
Pages (from-to)230-239
Number of pages10
JournalPediatric Endocrinology Reviews
Volume11 Suppl 2
StatePublished - 2014
Externally publishedYes

Fingerprint

Eunuchism
Puberty
Gonadotropins
Fertility
Testosterone
Therapeutics
Delayed Puberty
Virilism
Patient Preference
Gonadotropin-Releasing Hormone
Bone Density
Androgens
Muscles
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism

Cite this

Watson, S., Fuqua, J., & Lee, P. A. (2014). Treatment of hypogonadism in males. Pediatric Endocrinology Reviews, 11 Suppl 2, 230-239.

Treatment of hypogonadism in males. / Watson, Sara; Fuqua, John; Lee, Peter A.

In: Pediatric Endocrinology Reviews, Vol. 11 Suppl 2, 2014, p. 230-239.

Research output: Contribution to journalArticle

Watson, S, Fuqua, J & Lee, PA 2014, 'Treatment of hypogonadism in males.', Pediatric Endocrinology Reviews, vol. 11 Suppl 2, pp. 230-239.
Watson, Sara ; Fuqua, John ; Lee, Peter A. / Treatment of hypogonadism in males. In: Pediatric Endocrinology Reviews. 2014 ; Vol. 11 Suppl 2. pp. 230-239.
@article{097839201f3f4e2d9a5ae2bd0ffeaa31,
title = "Treatment of hypogonadism in males.",
abstract = "The treatment of adolescent males with hypogonadism using testosterone is dependent on the underlying diagnosis as well as the patient's and family's preferences. Those with testicular failure, always a pathologic condition, begin lifelong therapy, while short-term therapy is often begun for those who have a delayed puberty. There is a wide variety of testosterone formulations available, with differences in adverse events sometimes associated with the method of administration. The goals of treatment involve stimulating physical puberty, including achievement of virilization, a normal muscle mass and bone mineral density for age, and improvement in psychosocial wellbeing. While androgen therapy results in physical changes of puberty, the potential for fertility must be considered for those with permanent gonadotropin deficiency. in this population, therapy with gonadotropins or gonadotropin releasing hormone may be effective. For those with testicular failure, fertility may be possible but requires assisted reproductive procedures.",
author = "Sara Watson and John Fuqua and Lee, {Peter A.}",
year = "2014",
language = "English",
volume = "11 Suppl 2",
pages = "230--239",
journal = "Pediatric Endocrinology Reviews",
issn = "1565-4753",
publisher = "YS Medical Media Ltd.",

}

TY - JOUR

T1 - Treatment of hypogonadism in males.

AU - Watson, Sara

AU - Fuqua, John

AU - Lee, Peter A.

PY - 2014

Y1 - 2014

N2 - The treatment of adolescent males with hypogonadism using testosterone is dependent on the underlying diagnosis as well as the patient's and family's preferences. Those with testicular failure, always a pathologic condition, begin lifelong therapy, while short-term therapy is often begun for those who have a delayed puberty. There is a wide variety of testosterone formulations available, with differences in adverse events sometimes associated with the method of administration. The goals of treatment involve stimulating physical puberty, including achievement of virilization, a normal muscle mass and bone mineral density for age, and improvement in psychosocial wellbeing. While androgen therapy results in physical changes of puberty, the potential for fertility must be considered for those with permanent gonadotropin deficiency. in this population, therapy with gonadotropins or gonadotropin releasing hormone may be effective. For those with testicular failure, fertility may be possible but requires assisted reproductive procedures.

AB - The treatment of adolescent males with hypogonadism using testosterone is dependent on the underlying diagnosis as well as the patient's and family's preferences. Those with testicular failure, always a pathologic condition, begin lifelong therapy, while short-term therapy is often begun for those who have a delayed puberty. There is a wide variety of testosterone formulations available, with differences in adverse events sometimes associated with the method of administration. The goals of treatment involve stimulating physical puberty, including achievement of virilization, a normal muscle mass and bone mineral density for age, and improvement in psychosocial wellbeing. While androgen therapy results in physical changes of puberty, the potential for fertility must be considered for those with permanent gonadotropin deficiency. in this population, therapy with gonadotropins or gonadotropin releasing hormone may be effective. For those with testicular failure, fertility may be possible but requires assisted reproductive procedures.

UR - http://www.scopus.com/inward/record.url?scp=84899154854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899154854&partnerID=8YFLogxK

M3 - Article

VL - 11 Suppl 2

SP - 230

EP - 239

JO - Pediatric Endocrinology Reviews

JF - Pediatric Endocrinology Reviews

SN - 1565-4753

ER -